Evidence map›Paper›PMID 39516200›Full record

ArticleNature communications2024

VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction.

Harris E Blankenship, Kelsey A Carter, Kevin D Pham, Nina T Cassidy, Andrea N Markiewicz, Michael I Thellmann, Amanda L Sharpe, Willard M Freeman, Michael J Beckstead

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Small-Conductance CaNeuroscience bulletin · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Neurotransmitter Systems in Alzheimer's Disease.Current issues in molecular biology · 2026
    Review
  6. Alzheimer's Pathology Enhances Excitatory Synaptic Input and Integration in VTA Dopamine Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Harris E BlankenshipAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID 0000-0001-7570-4895
Kelsey A CarterAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Kevin D PhamGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Nina T CassidyAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Andrea N MarkiewiczAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Michael I ThellmannAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID 0009-0002-4928-8204
Amanda L SharpeDepartment of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID 0000-0003-3971-5946
Willard M FreemanGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID 0000-0001-7027-999X
Michael J BecksteadAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. mike-beckstead@omrf.org.ORCID 0000-0002-1574-530X

Funding

Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael T Kinter · 2015 to 2026
$13.9M
Sex divergence and cell specificity of age-related hippocampal DNA modificationsR01AG059430 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2019 to 2023
$2.7M
Effects of dietary restriction on age-related neurophysiological adaptations: frombehavior to single dopaminergic neuronsR01AG052606 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BECKSTEAD, MICHAEL J · 2016 to 2020
$2.1M
Ventral tegmental area involvement in Alzheimer's pathologyR21AG072811 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI BECKSTEAD, MICHAEL J · 2021 to 2021
$481k
Multimodal ventral tegmental area decrements in a mouse Alzheimer's modelF31AG079620 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BLANKENSHIP, HARRIS · 2022 to 2024
$110k
Plasticity of GABA input to VTA dopamine neurons in opioid use disordersI01BX005396 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI BECKSTEAD, MICHAEL J · 2022 to 2025
–
BLRD Research Career Scientist Award ApplicationIK6BX006033 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI FREEMAN, WILLARD M · 2022 to 2025
–
BLRD VA I01 BX005396BLRD VA IK6 BX006033NIA NIH HHS F31 AG079620NIA NIH HHS P30 AG050911NIA NIH HHS R01 AG052606NIA NIH HHS R01 AG059430NIA NIH HHS R21 AG072811U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30 AG050911, R01 AG059430U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21 AG072811, R01 AG052606
6 · The paper itself

Abstract

Alzheimer's disease (AD) patients exhibit neuropsychiatric symptoms that extend beyond classical cognitive deficits, suggesting involvement of subcortical areas. Here, we investigated the role of midbrain dopamine (DA) neurons in AD using the amyloid + tau-driven 3xTg-AD mouse model. We found deficits in reward-based operant learning in AD mice, suggesting possible VTA DA neuron dysregulation. Physiological assessment revealed hyperexcitability and disrupted firing in DA neurons caused by reduced activity of small-conductance calcium-activated potassium (SK) channels. RNA sequencing from contents of single patch-clamped DA neurons (Patch-seq) identified up-regulation of the SK channel modulator casein kinase 2 (CK2), which we corroborated by immunohistochemical protein analysis. Pharmacological inhibition of CK2 restored SK channel activity and normal firing patterns in 3xTg-AD mice. These findings identify a mechanism of ion channel dysregulation in VTA DA neurons that could contribute to behavioral abnormalities in AD, paving the way for novel treatment strategies.

Indexed as

Alzheimer DiseaseCasein Kinase IIDisease Models, AnimalDopaminergic NeuronsMice, TransgenicSmall-Conductance Calcium-Activated Potassium ChannelsVentral Tegmental AreaAnimalsHumansMaleMiceMice, Inbred C57BLtau ProteinsCasein Kinase IISmall-Conductance Calcium-Activated Potassium Channelstau Proteins

Identifiers

PMID39516200
PMCPMC11549218

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.